ev3 Inc. Market Share Analysis

Report Overview

Table of Contents

636.73

Select License Type

£636.73	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,273.46	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£1,910.18	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£636.73	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Company Profile
Country	Global
Published	21 September 2011
Number of Pages	137
Report Delivery	Email
Delivery Lead Time	1-3 hours, 24 hour max
Publisher	GlobalData
File Format	-

ev3 Inc. Market Share Analysis - Our new report, "ev3 Inc. Market Share Analysis" provides in-depth information on ev3 Inc.'s market position in the different medical equipment markets it operates in. The report provides ev3 Inc. market share information in two key market categories – Interventional Neurology and Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets ev3 Inc. operates in – Interventional Neurology and Peripheral Vascular Devices.
- ev3 Inc.'s company shares (in Revenues) information for all the key countries the company has presence in – Brazil, United Kingdom, Spain, Italy, Germany, France, Japan, India, China, Australia, Canada and United States.
- All the key data-points are for 2010 and cover all the key regions – South and Central America, Europe, Asia-Pacific, Middle East and Africa and North America.
- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in..
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, ev3 Inc. operates in.
- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to ev3 Inc.'s market positions.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£636.73	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,273.46	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£1,910.18	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£636.73	Add to Wishlist
Change Currency	GBP EURO USD

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets/Categories Covered 13
3.1 Interventional Neurology 13
3.2 Peripheral Vascular Devices 13
4 Company Snapshot 14
4.1 Key Information 14
4.2 Company Overview 14
4.3 SWOT Snapshot 14
5 Business Description 15
5.1 Business Overview 15
5.2 Neurovascular Segment 15
5.2.1 Overview 15
5.2.2 Financials 15
5.2.3 Market View 15
5.2.4 Key Strategies 16
5.3 Peripheral Vascular Segment 16
5.3.1 Overview 16
5.3.2 Financials 16
5.3.3 Market View 16
5.3.4 Key Strategies 16
5.4 Major Products and Services 17
5.4.1 Overview 17
6 History 19
7 SWOT Analysis 21
7.1 Overview 21
7.2 ev3 Inc. Strengths 21
7.2.1 Efficient Use of Resources 21
7.2.2 Expanding Operating Margin 22
7.2.3 Diversified Endovascular Product Portfolio 22
7.2.4 Expanding Market Share in the Sector 22
7.2.5 Sturdy Research Activities 22
7.3 ev3 Inc. Weaknesses 23
7.3.1 Decreased Demand for Plaque Excision Products 23
7.3.2 Product Recalls 23
7.4 ev3 Inc. Opportunities 23
7.4.1 Growing Peripheral Vascular Device Market 23
7.4.2 Growing Aged Population 23
7.4.3 Market Growth in Emerging Economies 24
7.4.4 Strategic Acquisitions 24
7.4.5 Robust Pipeline Products 24
7.5 ev3 Inc. Threats 24
7.5.1 Stringent Government Regulations 24
7.5.2 Rapid Technological Changes 25
7.5.3 Competitive Landscape 25
7.5.4 Industry Consolidation Challenges 25
7.5.5 Cost Containment Pressures 25
8 Competitors 26
9 Competitive Landscape 27
9.1 Peripheral Vascular Devices, Global, Market Share (%), 2010 27
9.2 Interventional Neurology, Global, Market Share (%), 2010 29
10 ev3 Inc. Medical Equipment Market Share Analysis 30
10.1 ev3 Inc., Global, Market Share (2010) 30
10.2 ev3 Inc., Asia-Pacific, Market Share (2010) 32
10.2.1 ev3 Inc., Australia, Market Share (2010) 34
10.2.2 ev3 Inc., China, Market Share (2010) 36
10.2.3 ev3 Inc., India, Market Share (2010) 38
10.2.4 ev3 Inc., Japan, Market Share (2010) 40
10.2.5 ev3 Inc., Other Asia-Pacific, Market Share (2010) 42
10.3 ev3 Inc., Europe, Market Share (2010) 44
10.3.1 ev3 Inc., France, Market Share (2010) 46
10.3.2 ev3 Inc., Germany, Market Share (2010) 48
10.3.3 ev3 Inc., Italy, Market Share (2010) 50
10.3.4 ev3 Inc., Spain, Market Share (2010) 52
10.3.5 ev3 Inc., United Kingdom, Market Share (2010) 54
10.3.6 ev3 Inc., Other Europe, Market Share (2010) 56
10.4 ev3 Inc., Middle East and Africa, Market Share (2010) 58
10.5 ev3 Inc., North America, Market Share (2010) 59
10.5.1 ev3 Inc., Canada, Market Share (2010) 61
10.5.2 ev3 Inc., United States, Market Share (2010) 63
10.6 ev3 Inc., South and Central America, Market Share (2010) 65
10.6.1 ev3 Inc., Brazil, Market Share (2010) 67
10.6.2 ev3 Inc., Other South and Central America, Market Share (2010) 69
11 Key Employees 71
12 Key Employee Biographies 72
13 Locations And Subsidiaries 73
13.1 Head Office 73
13.2 Other Locations & Subsidiaries 73
14 Financial Deals Landscape 75
14.1 ev3 Inc., Deals Volume Summary, 2006 to YTD 2011 75
15 ev3 Inc. Detailed Deal Summary 77
15.1 Venture Financing 77
15.1.1 Chestnut Medical Technologies Secures $7.8 Million In Venture Financing 77
15.1.2 Chestnut Medical Technologies Secures $0.83 Million In Series B Financing 78
15.1.3 Alsius Secures $10 Million In Series E Financing 79
15.2 Partnerships 80
15.2.1 ev3 Terminates Agreement With Bacchus Vascular 80
15.2.2 ev3 Enters Into Distribution Agreement With Lepu Medical 81
15.2.3 Volcano Signs An Agreement With ev3 82
15.2.4 ev3 And Foxhollow Enter Into Distribution Agreement 83
15.2.5 ev3 Enters Into An Agreement With Invatec 84
15.3 Equity Offering 85
15.3.1 ev3 Completes Public Offering Of $47.5 Million 85
15.3.2 ev3 Completes Initial Public Offering Of $164.71 Million 87
15.3.3 Micro Therapeutics Completes Private Placement Of 7% Exchangeable Notes For $21 Million 88
15.4 Asset Transactions 89
15.4.1 Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular 89
15.4.2 Edwards Acquires Percutaneous Heart Valve Technology From ev3 91
15.5 Acquisition 92
15.5.1 Covidien Completes Acquisition Of ev3 For $2.6 Billion 92
15.5.2 ev3 Completes Acquisition Of Chestnut Medical Technologies 94
15.5.3 ev3 Acquires Foxhollow Technologies 96
15.5.4 ev3 Acquires Micro Therapeutics 98
16 Recent Developments 99
16.1 Strategy And Business Planning 99
16.1.1 Jun 11, 2010: Ev3 To Expand Peripheral Vascular Manufacturing Facility In Minnesota 99
16.2 Financial Announcements 99
16.2.1 Apr 29, 2010: ev3 Reports Net Income Of $9.8 Million In Q1 2010 99
16.2.2 Feb 18, 2010: ev3 Reports Net Income Of $41.9 Million In 2009 100
16.2.3 Oct 27, 2009: ev3 Reports Net Income Of $6.7 Million In Q3 2009 101
16.2.4 Jul 28, 2009: ev3 Posts Net Income Of $24 Million In Q2 2009 103
16.2.5 Apr 28, 2009: ev3 Posts Net Loss Of $1.8 Million In Q1 2009 103
16.2.6 Feb 24, 2009: ev3 Reports 2008 Results 104
16.2.7 Oct 31, 2008: ev3 Reports 3Q 2008 Results 106
16.2.8 Jul 28, 2008: ev3 Reports 2Q 2008 Results 108
16.2.9 May 02, 2008: ev3 Reports Q1 2008 Results 110
16.2.10 Apr 18, 2008: ev3 To Declare Q1 2008 Results 111
16.2.11 Feb 22, 2008: ev3 Reports Q4 2007 Results 111
16.2.12 Feb 08, 2008: ev3 To Declare Q4 And 2007 Results 113
16.2.13 Jan 07, 2008: ev3 Reports Preliminary Q4 2007 Results and Revised 2008 Guidance 113
16.2.14 Oct 31, 2007: ev3 Reports Q3 2007 Results 114
16.2.15 Jul 22, 2007: ev3 Reports Q2 2007 Results 116
16.2.16 Apr 27, 2007: ev3 Reports Q1 2007 Results 118
16.2.17 Feb 20, 2007: ev3 Reports Year-End 2006 Results 119
16.2.18 Oct 20, 2006: ev3 Reports Q3 2006 Results 120
16.2.19 Jul 28, 2006: ev3 Reports Q2 2006 Results 121
16.3 Corporate Communications 123
16.3.1 Dec 15, 2009: Ev3 Promotes Pascal E.R. Girin To EVP, COO And David Mowry To SVP, President 123
16.3.2 Jan 09, 2009: ev3 Announces Management Changes 123
16.3.3 Dec 03, 2008: ev3 Appoints New Board Member 124
16.3.4 Aug 04, 2008: ev3 Appoints New Board Member 124
16.3.5 Jul 21, 2008: ev3 Announces Management Changes 124
16.3.6 Apr 07, 2008: ev3 Announces Management Changes 125
16.3.7 Feb 08, 2008: ev3 Chief Scientist And Board Member Resigns 125
16.3.8 Feb 27, 2007: ev3 Appoints New Director 126
16.4 Legal and Regulatory 126
16.4.1 Nov 02, 2010: CSI Settles Employee Lawsuit With ev3 126
16.4.2 Jul 06, 2010: ev3 Agrees To Settle Stockholder Litigation 126
16.4.3 Jun 01, 2010: Finkelstein Thompson LLP Announces Investigation Of ev3 127
16.5 Product News 127
16.5.1 Apr 11, 2011: Covidien Completes Patient Enrollment In Post-Market Study Of SilverHawk Atherectomy System 127
16.5.2 Dec 23, 2010: ev3 Initiates Voluntary Recall Of Specific Lots Of NanoCross 0.014" OTW PTA Dilatation Catheter 127
16.5.3 Jun 21, 2010: ev3 Announces Acceptance Of PMA Application Of Pipeline Embolization Device By FDA 128
16.5.4 May 18, 2010: ev3 Files PMA Application For Its Pipeline Embolization Device 128
16.5.5 May 10, 2010: ev3 Endovascular To Complete SWIFT Study For Solitaire FR Revascularization Device In Second Half Of 2011 129
16.5.6 Apr 26, 2010: ev3 Announces Completion Of Patient Enrollment In DURABILITY II Study For EverFlex Self-Expanding Stent System 129
16.5.7 Jan 05, 2010: ev3 Announces Trailblazer Support Catheter Recall 130
16.5.8 ec 09, 2008: ev3 Inc Receives FDA Clearance To Market EverCross Peripheral Angioplasty Balloons 130
16.5.9 Dec 18, 2007: ev3 Introduces New Enhanced Offering For The Treatment Of Peripheral Artery Disease 130
16.5.10 Dec 18, 2007: ev3 Introduces New Enhanced Offerings For The Treatment Of Peripheral Artery Disease 130
16.5.11 Jun 04, 2007: ev3 Receives Conditional IDE Approval To Study Use Of Protégé EverFlex Self-Expanding Stent System In The Treatment Of Peripheral Artery Disease 131
16.5.12 Apr 02, 2007: FoxHollow Filled 510(k) For The NightHawk System 131
17 Appendix 132
17.1 Research Methodology 133
17.2 Secondary Research 133
17.3 Primary Research 134
17.4 Models 134
17.5 Forecasts 135
17.6 Expert Panels 135
17.7 GlobalData Consulting 135
17.8 Currency Conversion 136
17.9 Contact Us 137
17.10 Disclaimer 137

List of Tables

Table 1: ev3 Inc., Key Facts, 2010 14
Table 2: ev3 Inc., SWOT Analysis, 2010 21
Table 3: Peripheral Vascular Devices, Global, Company Share by Revenue ($m), 2010 28
Table 4: Interventional Neurology, Global, Company Share by Revenue ($m), 2010 29
Table 5: ev3 Inc., Medical Equipment, Global, Revenue ($m) and Market Share (%), 2010 31
Table 6: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%), 2010 33
Table 7: ev3 Inc., Medical Equipment, Australia, Revenue ($m) and Market Share (%), 2010 35
Table 8: ev3 Inc., Medical Equipment, China, Revenue ($m) and Market Share (%), 2010 37
Table 9: ev3 Inc., Medical Equipment, India, Revenue ($m) and Market Share (%), 2010 39
Table 10: ev3 Inc., Medical Equipment, Japan, Revenue ($m) and Market Share (%), 2010 41
Table 11: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%), 2010 43
Table 12: ev3 Inc., Medical Equipment, Europe, Revenue ($m) and Market Share (%), 2010 45
Table 13: ev3 Inc., Medical Equipment, France, Revenue ($m) and Market Share (%), 2010 47
Table 14: ev3 Inc., Medical Equipment, Germany, Revenue ($m) and Market Share (%), 2010 49
Table 15: ev3 Inc., Medical Equipment, Italy, Revenue ($m) and Market Share (%), 2010 51
Table 16: ev3 Inc., Medical Equipment, Spain, Revenue ($m) and Market Share (%), 2010 53
Table 17: ev3 Inc., Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%), 2010 55
Table 18: ev3 Inc., Medical Equipment, Other Europe, Revenue ($m) and Market Share (%), 2010 57
Table 19: ev3 Inc., Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%), 2010 58
Table 20: ev3 Inc., Medical Equipment, North America, Revenue ($m) and Market Share (%), 2010 60
Table 21: ev3 Inc., Medical Equipment, Canada, Revenue ($m) and Market Share (%), 2010 62
Table 22: ev3 Inc., Medical Equipment, United States, Revenue ($m) and Market Share (%), 2010 64
Table 23: ev3 Inc., Medical Equipment, South and Central America, Revenue ($m) and Market Share (%), 2010 66
Table 24: ev3 Inc., Medical Equipment, Brazil, Revenue ($m) and Market Share (%), 2010 68
Table 25: ev3 Inc., Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%), 2010 70
Table 26: ev3 Inc., Key Employees 71
Table 27: ev3 Inc., Other Locations 73
Table 28: ev3 Inc., Subsidiaries 74
Table 29: ev3 Inc., Deals Volume Summary, 2006 to YTD 2011 75
Table 30: ev3 Inc., Deals Summary, 2006 to YTD 2011 76
Table 31: Chestnut Medical Technologies Secures $7.8 Million In Venture Financing 77
Table 32: Chestnut Medical Technologies Secures $0.83 Million In Series B Financing 78
Table 33: Alsius Secures $10 Million In Series E Financing 79
Table 34: ev3 Terminates Agreement With Bacchus Vascular 80
Table 35: ev3 Enters Into Distribution Agreement With Lepu Medical 81
Table 36: Volcano Signs An Agreement With ev3 82
Table 37: ev3 And Foxhollow Enter Into Distribution Agreement 83
Table 38: ev3 Enters Into An Agreement With Invatec 84
Table 39: ev3 Completes Public Offering Of $47.5 Million 85
Table 40: ev3 Completes Initial Public Offering Of $164.71 Million 87
Table 41: Micro Therapeutics Completes Private Placement Of 7% Exchangeable Notes For $21 Million 88
Table 42: Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular 89
Table 43: Edwards Acquires Percutaneous Heart Valve Technology From ev3 91
Table 44: Covidien Completes Acquisition Of ev3 For $2.6 Billion 92
Table 45: ev3 Completes Acquisition Of Chestnut Medical Technologies 94
Table 46: ev3 Acquires Foxhollow Technologies 96
Table 47: ev3 Acquires Micro Therapeutics 98
Table 48: USD to Local Currency, Average Exchange Rate, 2010 136

List of Figures

Figure 1: Peripheral Vascular Devices, Global, Market Share (%), 2010 27
Figure 2: Interventional Neurology, Global, Market Share (%), 2010 29
Figure 3: ev3 Inc., Medical Equipment, Global, Revenue Share (%), 2010 30
Figure 4: ev3 Inc., Medical Equipment, Global, Market Share (%), 2010 31
Figure 5: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue Share (%), 2010 32
Figure 6: ev3 Inc., Medical Equipment, Asia-Pacific, Market Share (%), 2010 33
Figure 7: ev3 Inc., Medical Equipment, Australia, Revenue Share (%), 2010 34
Figure 8: ev3 Inc., Medical Equipment, Australia, Market Share (%), 2010 35
Figure 9: ev3 Inc., Medical Equipment, China, Revenue Share (%), 2010 36
Figure 10: ev3 Inc., Medical Equipment, China, Market Share (%), 2010 37
Figure 11: ev3 Inc., Medical Equipment, India, Revenue Share (%), 2010 38
Figure 12: ev3 Inc., Medical Equipment, India, Market Share (%), 2010 39
Figure 13: ev3 Inc., Medical Equipment, Japan, Revenue Share (%), 2010 40
Figure 14: ev3 Inc., Medical Equipment, Japan, Market Share (%), 2010 41
Figure 15: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue Share (%), 2010 42
Figure 16: ev3 Inc., Medical Equipment, Other Asia-Pacific, Market Share (%), 2010 43
Figure 17: ev3 Inc., Medical Equipment, Europe, Revenue Share (%), 2010 44
Figure 18: ev3 Inc., Medical Equipment, Europe, Market Share (%), 2010 45
Figure 19: ev3 Inc., Medical Equipment, France, Revenue Share (%), 2010 46
Figure 20: ev3 Inc., Medical Equipment, France, Market Share (%), 2010 47
Figure 21: ev3 Inc., Medical Equipment, Germany, Revenue Share (%), 2010 48
Figure 22: ev3 Inc., Medical Equipment, Germany, Market Share (%), 2010 49
Figure 23: ev3 Inc., Medical Equipment, Italy, Revenue Share (%), 2010 50
Figure 24: ev3 Inc., Medical Equipment, Italy, Market Share (%), 2010 51
Figure 25: ev3 Inc., Medical Equipment, Spain, Revenue Share (%), 2010 52
Figure 26: ev3 Inc., Medical Equipment, Spain, Market Share (%), 2010 53
Figure 27: ev3 Inc., Medical Equipment, United Kingdom, Revenue Share (%), 2010 54
Figure 28: ev3 Inc., Medical Equipment, United Kingdom, Market Share (%), 2010 55
Figure 29: ev3 Inc., Medical Equipment, Other Europe, Revenue Share (%), 2010 56
Figure 30: ev3 Inc., Medical Equipment, Other Europe, Market Share (%), 2010 57
Figure 31: ev3 Inc., Medical Equipment, North America, Revenue Share (%), 2010 59
Figure 32: ev3 Inc., Medical Equipment, North America, Market Share (%), 2010 60
Figure 33: ev3 Inc., Medical Equipment, Canada, Revenue Share (%), 2010 61
Figure 34: ev3 Inc., Medical Equipment, Canada, Market Share (%), 2010 62
Figure 35: ev3 Inc., Medical Equipment, United States, Revenue Share (%), 2010 63
Figure 36: ev3 Inc., Medical Equipment, United States, Market Share (%), 2010 64
Figure 37: ev3 Inc., Medical Equipment, South and Central America, Revenue Share (%), 2010 65
Figure 38: ev3 Inc., Medical Equipment, South and Central America, Market Share (%), 2010 66
Figure 39: ev3 Inc., Medical Equipment, Brazil, Revenue Share (%), 2010 67
Figure 40: ev3 Inc., Medical Equipment, Brazil, Market Share (%), 2010 68
Figure 41: ev3 Inc., Medical Equipment, Other South and Central America, Revenue Share (%), 2010 69
Figure 42: ev3 Inc., Medical Equipment, Other South and Central America, Market Share (%), 2010 70
Figure 43: ev3 Inc., Deals Volume Summary, 2006 to YTD 2011 75

Companies Mentioned

Abbott Laboratories
Accuray Incorporated
ASAHI INTECC CO., LTD.
B. Braun Melsungen AG
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C.R. Bard, Inc.
Cadwell Laboratories, Inc.
CareFusion Corporation
Cordis Corporation
Covidien plc
Cyberonics, Inc.
DePuy, Inc.
Edwards Lifesciences Corporation
Elekta AB
Goodman Co., Ltd.
Integra LifeSciences Holdings Corporation
MAQUET GmbH & Co. KG
Medtronic, Inc.
Micrus Endovascular Corporation
Mizuho Ikakogyo Co., Ltd.
Natus Medical Incorporated
Nihon Kohden Corporation
Philips Healthcare
Sorin Group
St. Jude Medical, Inc.
Terumo Corporation
Thoratec Corporation

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

ev3 Inc. Market Share Analysis

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

ev3 Inc. Market Share Analysis

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Competitor Tracking

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Republic of the Congo
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel